Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2018-08-13 2018-08-13
Drug Identification Number 02237815 02237815
Brand name ERWINASE ERWINASE
Common or Proper name L-asparaginase L-asparaginase
Company Name JAZZ PHARMACEUTICALS FRANCE SAS JAZZ PHARMACEUTICALS FRANCE SAS
Ingredients ASPARAGINASE ASPARAGINASE
Strength(s) 10000UNIT 10000UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 3 mL vials (20 vials per carton) 3 mL vials (20 vials per carton)
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2018-07-30 2018-07-30
Estimated end date 2018-08-10 2018-08-10
Actual end date 2018-08-10 2018-08-10
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Unanticipated delay in the scheduled release of the next batch of product Unanticipated delay in the scheduled release of the next batch of product
Health Canada comments